Field loss may not be the only visual deficit resulting from macular damage while resulting functional losses may impair facial recognition, according to new research published in JAMA Ophthalmology.
Field loss may not be the only visual deficit resulting from macular damage while resulting functional losses may impair facial recognition, according to new research published in JAMA Ophthalmology.
Although it has been recently reported glaucomatous macular damage is directly correlated with diminished facial recognition in eyes with good central vision, it is possible this damage is not limited to impairment related to Humphrey visual field defects, authors wrote.
To investigate the association between facial recognition and macular structural damage, researchers carried out spectral-domain ocular coherence tomography (SD-OCT) retinal ganglion cell and inner plexiform layer (RGC+) assessments on patients with primary open-angle glaucoma in 1 or both eyes.
Study participants were recruited between March 2019 and April 2019 and underwent a comprehensive ophthalmologic examination. Using RGC+, macular damage in the better seeing eye was classified as focal, diffuse, or mixed. Investigators assessed facial recognition via the Cambridge Face Memory Test.
Of the 68 better-seeing eyes included in the study, 54 had structural macular damage and 14 did not, while no differences in age, number of antiglaucoma medications, logMAR visual acuity, proportion with early cataract, spherical equivalence, or significant astigmatism were reported between groups.
Analyses of the better eyes revealed:
“In the present study, we show that decreased mean RGC+ in the better-seeing eye was independently associated with diminished facial recognition, even after adjusting for central visual field loss,” researchers wrote.
Findings also indicate diffuse structural macular damage in the better seeing eye could be associated with diminished facial recognition compared with focal structural macular damage. Future studies with larger sample sizes are needed to validate this association.
“These findings generally support previous work showing functional differences between patients with diffuse and focal macular damage,” authors concluded. “It also suggests that the global effect of diffuse damage appears to result in worsened visual function.”
Reference
Khan SS, Hirji SH, Hood DC, Liebmann JM, and Blumberg DM. Association of macular optical coherence tomography measures and deficits in facial recognition in patients with glaucoma. JAMA Ophthalmol. Published online March 11, 2021. doi:10.1001/jamaophthalmol.2021.0137
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Imetelstat Offers Benefits for Patients With MDS Who Are Red Blood Cell–Transfusion Dependent
December 5th 2023The past year has offered new hope for patients with lower-risk myelodysplastic syndromes. Besides imetelstat, which has an FDA deadline for action of June 2024, the agency approved luspatercept, which has a different mechanism of action.
Read More
Trastuzumab Biosimilar Gets Go Ahead in EU for HER2+ Breast and Metastatic Gastric Cancers
December 5th 2023EG12014, a biosimilar of the anti-HER2 monoclonal antibody trastuzumab, has received a marketing authorization from the European Commission for use in the European Union (EU) for the treatment of patients with HER2-positive (HER2+) breast and metastatic gastric cancer; these are the same indications that trastuzumab holds in the European Union.
Read More